Advanced Search

Refine my results

Document type

Institution

Specific Collection

Language

Author

Domain

Keyword

Sorted by: Date of deposit
5 results 1
Postprint
Consortium of Swiss Academic Libraries

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Borner, M. ; Koeberle, D. ; Von Moos, R. ; Saletti, P. ; Rauch, D. ; Hess, V. ; Trojan, A. ; Helbling, D. ; Pestalozzi, B. ; Caspar, C. ; Ruhstaller, T. ; Roth, A. ; Kappeler, A. ; Dietrich, D. ; Lanz, D. ; Mingrone, W.

In: Annals of Oncology, 2008, vol. 19, no. 7, p. 1288-1292

Postprint
Consortium of Swiss Academic Libraries

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

Bernier, J. ; Bonner, J. ; Vermorken, J. B. ; Bensadoun, R.-J ; Dummer, R. ; Giralt, J. ; Kornek, G. ; Hartley, A. ; Mesia, R. ; Robert, C. ; Segaert, S. ; Ang, K. K.

In: Annals of Oncology, 2007, vol. 19, no. 1, p. 142-149

Postprint
Consortium of Swiss Academic Libraries

Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines

Bernier, J. ; Russi, E. G. ; Homey, B. ; Merlano, M. C. ; Mesía, R. ; Peyrade, F. ; Budach, W.

In: Annals of Oncology, 2011, vol. 22, no. 10, p. 2191-2200

Postprint
Consortium of Swiss Academic Libraries

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Joerger, M. ; Matter-Walstra, K. ; Früh, M. ; Kühnel, U. ; Szucs, T. ; Pestalozzi, B. ; Schwenkglenks, M.

In: Annals of Oncology, 2011, vol. 22, no. 3, p. 567-574

Postprint
Consortium of Swiss Academic Libraries

A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy

Zhang, W. ; Winder, T. ; Ning, Y. ; Pohl, A. ; Yang, D. ; Kahn, M. ; Lurje, G. ; LaBonte, M. J. ; Wilson, P. M. ; Gordon, M. A. ; Hu-Lieskovan, S. ; Mauro, D. J. ; Langer, C. ; Rowinsky, E. K. ; Lenz, H.-J

In: Annals of Oncology, 2011, vol. 22, no. 1, p. 104-109

5 results 1